Search - tctmd.com

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Yael L. Maxwell

April 10, 2014

News Daily News

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

April 09, 2014

News Daily News

STEMI Patients Transferred for Primary PCI Show More Medication Errors

Jason Kahn

April 03, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

News Conference News ACC 2014

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Jason Kahn

March 29, 2014

News Daily News

Ultrasound-Assisted Thrombolysis Effective in Higher-Risk Pulmonary Embolism

L.A. McKeown

January 27, 2014

Advertisement

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

HEAT-PPCI Publicado: El Discrepante Hallazgo de la Superioridad de la Heparina sobre la Bivalirudina en PCI Primarias Sigue Confundiendo

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

ACUITY分项研究： Syntax评分与NSTE-ACS患者的支架内血栓形成有关联

ACUITY Substudy: Syntax Score Correlates with Stent Thrombosis in NSTE-ACS Patients

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

STEMI Patients Transferred for Primary PCI Show More Medication Errors

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

EUROMAX: Bivalirudin May Hold Key to Solving Problem of Early ST After Primary PCI

Ultrasound-Assisted Thrombolysis Effective in Higher-Risk Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content